2026 Crohn's and Colitis Conference

Brookield, WI US
April 18, 2026

This activity will focus on enhancing physicians’ ability to select and apply contemporary, evidence-based therapies for inflammatory bowel disease (IBD), with special attention to complex patient populations. Learners will review the mechanisms of action, indications, and optimal positioning of novel and emerging agents for ulcerative colitis and Crohn’s disease to improve both short- and long-term outcomes. Building on this foundation, the program will address the nuanced diagnostic workup and management of IBD in pregnant patients and older adults, emphasizing safety, comorbidities, and individualized risk–benefit assessment. Finally, participants will explore the treatment of other immune-mediated conditions commonly seen in patients with IBD, integrating immunomodulatory and biologic strategies to deliver coordinated, patient-centered care.

Target Audience

This is a program designed for physicians, nurses, pharmacists, nurse practitioners and physician assistants, allied health professionals, interns, residents, fellows and community partners specializing in Gastroenterology and Hepatology, Family Practice, Internal Medicine, Primary Care, General and Colorectal Surgery and Basic science.

Learning Objectives

Participants who engage in this educational intervention will be able to: 

  • Describe the mechanisms of action, clinical indications, and positioning of novel and emerging therapies for ulcerative colitis and Crohn’s disease to optimize short- and long-term disease outcomes.

  • Develop evidence-based diagnostic and management strategies for inflammatory bowel disease in pregnant patients and in older adults, taking into account safety, comorbidities, and special monitoring considerations.

  • Formulate treatment plans for immune-mediated conditions commonly encountered in patients with inflammatory bowel disease, including the selection and coordination of appropriate immunomodulatory and biologic therapies.

 

Additional information

Contact

Name: 
Kari Warren
Phone Number: 
+1 (414) 955-6850
Email: 
[email protected]
Course summary
Available credit: 
  • 4.75 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 4.75 Hours of Participation
    Hours of Participation credit.
Course opens: 
02/26/2026
Course expires: 
06/12/2026
Event starts: 
04/18/2026 - 7:30am CDT
Event ends: 
04/18/2026 - 1:00pm CDT
Cost:
$0.00
Add to calendar: 

Crohn’s and Colitis Foundation Conference: 
A Patient and Provider Point of Care Conference

7:30-7:45           Registration and Continental Breakfast

7:45-8:00           Welcome and Introductions

                           Dr. Poonam Beniwal-Patel & Crohn’s and Colitis Foundation

 8:00-8:45           Inflammatory Bowel Disease in the Older Population

                           Dr. Bharati Kochar, Keynote Speaker

 8:45-9:10           IBD Therapies: Intravenous (IV) vs Subcutaneous (SC)

                           Dr. Poonam Beniwal-Patel

 9:10-9:35           All about IL-23s

                           Dr. Dilpesh Agrawal

 9:35-10:00         Use of Biologics outside IBD: ICI Colitis, Refractory Celiac

                           Dr. Daniel Stein

 10:00-10:10         Questions

 10:10-10:20         BREAK

 10:20-10:45        IBD and Pregnancy

                            Dr. Rebecca Petrovski

 10:45-11:10        Managing Post-IBD Irritable Bowel Syndrome

                            Margo Gengler, PA-C

 11:10-11:35        Kono-S-Anastomosis for Crohn’s Disease

                            Dr. Jed Calata

 11:35-12:00        IBD Pathology: It’s in the Details

                            Dr. Mahmoud Mohamed Ali

 12:00-12:10        Questions/Wrap Up

 12:10-1:00          Working Lunch: Case Based Discussion

 

                                               

 

 

 

 

Brookfield Conference Center
325 S. Moorland Road
Brookield, WI 53005
United States
Brookfield Conference Center
Activity Director:
Poonam Beniwal-Patel, MD
 
Planning Committee:
Daniel Stein, MD
Dilpesh Agrawal, MD
 
Speaker/Presenters:
Poonam Beniwal-Patel, MD; Associate Professor of Medicine
Rebecca Petrovski, DO; Assistant Professor of Medicine
Margo Gengler, PA-C
Jed Calata, MD; Associate Professor of Surgery
Mahmoud Mohamed Ali, MD; Assistant Professor of Pathology
Daniel Stein, MD
Dilpesh Agrawal, MD
 
 
In accordance with the ACCME® Standards for Integrity and Independence in Accredited Continuing Education, Standard 3, all in control of content must disclose any relevant financial relationships. The following in control of content had no relevant financial relationships to disclose.
 
  • Poonam Beniwal-Patel, MD
  • Rebecca Petrovski, DO
  • Margo Gangler, PA-C
  • Jed Calata, MD
  • Mahmoud Mohamed Ali, MD
 
The following persons in control of content disclosed the following financial relationships which were reviewed via the MCW conflict of interest resolution process and resolved.
 

Name

Company

Role

Daniel Stein, MD
Abbvie, Lilly, Bristol Myers Squibb
Speaking/Teaching
Dilpesh Agrawal, MD
Janssen Biotech, Inc. 
Consultant
Bharati Kochar, MD
Pfizer, Inc., Takeda, Merck, Janssen
Consultant, Researcher, Advisory Board
 
 
ACCME Accreditation Statement:
The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
 
AMA Credit Designation Statement:
The Medical College of Wisconsin designates this Live Activity for a maximum of 4.75 AMA PRA Category 1 Credit(s)™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Hours of Participation for Allied Health Care Professionals:
The Medical College of Wisconsin designates this activity for up to 4.75 hours of participation for continuing education for allied health professionals. 

 

MOC Part II:

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 4.75 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Participation shared with American Board of Internal Medicine through PARS: Individual participants’ information will be shared with American Board of Internal Medicine through the ACCME Program and Activity Reporting System (PARS).

Available Credit

  • 4.75 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 4.75 Hours of Participation
    Hours of Participation credit.

TBD

Price

Cost:
$0.00
Please login or register to take this course.

Registration scams:

Registration for courses managed by MCW Office of Continuing Professional Development can only be completed through our portal at https://ocpe.mcw.edu/. Course registrations made through other sites cannot be honored. MCW Office of Continuing Professional Development is not able to refund fees paid through unaffiliated registration sites, such as eMedEvents.com, MedConfWorld.com, EventEgg.com, and 10times.com.  Please report any unauthorized websites or solicitations for registrations to cme@mcw

TO RECEIVE CE CREDIT   (Download: Claiming Credit Instructions)

Participants must: 

  • Complete the online evaluation in EthosCE  
  • Claim credit by June 12, 2026